# cfMSC Stem Cell Therapy Targeting COPD

> **NCT07477600** · PHASE1,PHASE2 · RECRUITING · sponsor: **Shenzhen Geno-Immune Medical Institute** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **BIOLOGICAL:** clonal fetal MSCs

## Key facts

- **NCT ID:** NCT07477600
- **Lead sponsor:** Shenzhen Geno-Immune Medical Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-10
- **Primary completion:** 2029-03-31
- **Final completion:** 2030-04-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07477600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07477600, "cfMSC Stem Cell Therapy Targeting COPD". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT07477600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*